The quality of YouTube videos on radiotherapy and prostatectomy for prostate cancer.

IF 1.9 4区 医学 Q3 UROLOGY & NEPHROLOGY
Natalie Wong, Paris-Ann Ingledew
{"title":"The quality of YouTube videos on radiotherapy and prostatectomy for prostate cancer.","authors":"Natalie Wong, Paris-Ann Ingledew","doi":"10.5489/cuaj.8523","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Prostate cancer ranks as the third leading cause of death among Canadian men and is primarily treated with radiotherapy and prostatectomy. Given YouTube's significant global traffic, patients often turn to it for information on treatment and side effects. This study assessed YouTube videos for prostate cancer patients, focusing on radiotherapy, prostatectomy, and side effect management.</p><p><strong>Methods: </strong>The study analyzed 50 YouTube videos, comparing their accuracy and coverage against the National Comprehensive Cancer Network (NCCN), UpToDate, and cancer.ca. Two raters were involved in the review of the videos to ensure inter-rater reliability.</p><p><strong>Results: </strong>Video lengths ranged from 1-60 minutes (mean 11 minutes) and creation dates ranged from 2012-2021. Videos were presented by physicians, patients, or allied health professionals (75%, 16%, and 8%, respectively). Results showed physician presenters had a Video Power Index (video popularity) of 23.45, while patient presenters had an average of 61.36 (almost three times as popular as physician-led videos). The overall accuracy of videos showed that 82% demonstrated completely accurate and detailed information, 18% showed partially complete information, and 76% showed no biased information. No false information was found in any videos.</p><p><strong>Conclusions: </strong>This study showed that while the YouTube informational videos included good coverage of treatment side effects, there were gaps in information regarding quality of life after treatment or management of side effects. Information from this study can benefit the provider-patient interaction, with the hope that healthcare providers create more videos on quality of life after treatment and management of side effects to satisfy patient needs.</p>","PeriodicalId":50613,"journal":{"name":"Cuaj-Canadian Urological Association Journal","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10841556/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cuaj-Canadian Urological Association Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5489/cuaj.8523","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Prostate cancer ranks as the third leading cause of death among Canadian men and is primarily treated with radiotherapy and prostatectomy. Given YouTube's significant global traffic, patients often turn to it for information on treatment and side effects. This study assessed YouTube videos for prostate cancer patients, focusing on radiotherapy, prostatectomy, and side effect management.

Methods: The study analyzed 50 YouTube videos, comparing their accuracy and coverage against the National Comprehensive Cancer Network (NCCN), UpToDate, and cancer.ca. Two raters were involved in the review of the videos to ensure inter-rater reliability.

Results: Video lengths ranged from 1-60 minutes (mean 11 minutes) and creation dates ranged from 2012-2021. Videos were presented by physicians, patients, or allied health professionals (75%, 16%, and 8%, respectively). Results showed physician presenters had a Video Power Index (video popularity) of 23.45, while patient presenters had an average of 61.36 (almost three times as popular as physician-led videos). The overall accuracy of videos showed that 82% demonstrated completely accurate and detailed information, 18% showed partially complete information, and 76% showed no biased information. No false information was found in any videos.

Conclusions: This study showed that while the YouTube informational videos included good coverage of treatment side effects, there were gaps in information regarding quality of life after treatment or management of side effects. Information from this study can benefit the provider-patient interaction, with the hope that healthcare providers create more videos on quality of life after treatment and management of side effects to satisfy patient needs.

关于癌症前列腺放射治疗和前列腺切除术的YouTube视频质量。
简介:在加拿大男性中,前列腺癌症是第三大死亡原因,主要接受放射治疗和前列腺切除术。鉴于YouTube在全球的巨大流量,患者经常向它寻求有关治疗和副作用的信息。这项研究评估了癌症患者的YouTube视频,重点是放疗、前列腺切除术和副作用管理。方法:该研究分析了50个YouTube视频,将其准确性和覆盖率与国家癌症综合网络(NCCN)、UpToDate和Cancer.ca进行了比较。两名评分员参与了视频的审查,以确保评分间的可靠性。结果:视频长度从1-60分钟不等(平均11分钟),创作日期从2012-2021年不等。视频由医生、患者或专职卫生专业人员呈现(分别为75%、16%和8%)。结果显示,医生主持的视频功率指数(视频受欢迎程度)为23.45,而患者主持的视频平均受欢迎程度为61.36(几乎是医生主导视频的三倍)。视频的总体准确性显示,82%的视频显示了完全准确和详细的信息,18%的视频显示部分完整的信息,76%的视频显示没有偏见的信息。在任何视频中都没有发现虚假信息。结论:这项研究表明,虽然YouTube上的信息视频对治疗副作用有很好的报道,但在治疗后的生活质量或副作用的管理方面存在信息空白。这项研究的信息可以有利于提供者与患者的互动,希望医疗保健提供者制作更多关于治疗后生活质量和副作用管理的视频,以满足患者的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cuaj-Canadian Urological Association Journal
Cuaj-Canadian Urological Association Journal 医学-泌尿学与肾脏学
CiteScore
2.80
自引率
10.50%
发文量
167
审稿时长
>12 weeks
期刊介绍: CUAJ is a a peer-reviewed, open-access journal devoted to promoting the highest standard of urological patient care through the publication of timely, relevant, evidence-based research and advocacy information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信